Brian Adams

Companies

• Kymera TherapeuticsGeneral counsel Sep 3, 2025 to now¹
• Relay TherapeuticsGeneral counsel Jul 15, 2020 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• RTRelay Therapeutics RLAY371,472 shares³$6.5M at $17.38Jul 29, 2025
• KTKymera Therapeutics KYMR50,254 shares⁴$5.4M at $108.14Sep 4, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 4, 2026Sold 2,137 shares at $117.57 of Kymera Therapeutics⁴
• Sep 4, 2026Sold 3,025 shares at $116.81 of Kymera Therapeutics⁴
• Sep 4, 2026Sold 1,209 shares at $115.55 of Kymera Therapeutics⁴
• Mar 2, 2026Granted 4,125 shares of Kymera Therapeutics⁵
• Sep 3, 2025Granted 52,500 shares of Kymera Therapeutics⁶
• Jul 29, 2025Sold 18,276 shares at $3.68 of Relay Therapeutics³
• Jul 28, 2025Sold 1,637 shares at $3.74 of Relay Therapeutics³
• Apr 30, 2025Sold 12,943 shares at $3.00 of Relay Therapeutics⁷
• Apr 28, 2025Sold 1,644 shares at $3.17 of Relay Therapeutics⁷
• Mar 27, 2025Sold 298 shares at $2.84 of Relay Therapeutics⁸
• Jan 30, 2025Sold 20,791 shares at $4.42 of Relay Therapeutics⁹
• Jan 28, 2025Granted 139,141 shares of Relay Therapeutics⁹
• Jan 28, 2025Sold 33,688 shares at $4.63 of Relay Therapeutics⁹
• Dec 27, 2024Sold 299 shares at $4.38 of Relay Therapeutics¹⁰
• Oct 28, 2024Sold 1,632 shares at $6.06 of Relay Therapeutics¹¹
• Sep 27, 2024Sold 295 shares at $7.51 of Relay Therapeutics¹²
• Jul 29, 2024Sold 1,638 shares at $8.85 of Relay Therapeutics¹³
• Jun 27, 2024Sold 295 shares at $6.26 of Relay Therapeutics¹⁴
• Apr 29, 2024Sold 1,623 shares at $6.38 of Relay Therapeutics¹⁵
• Mar 27, 2024Sold 348 shares at $7.70 of Relay Therapeutics¹⁶
• Jan 29, 2024Sold 1,929 shares at $9.64 of Relay Therapeutics¹⁷
• Jan 16, 2024Granted 200,000 shares of Relay Therapeutics¹⁸
• Dec 27, 2023Sold 294 shares at $11.51 of Relay Therapeutics¹⁹
• Oct 30, 2023Sold 1,632 shares at $6.03 of Relay Therapeutics²⁰
• Sep 27, 2023Sold 294 shares at $8.38 of Relay Therapeutics²¹